patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Re: 5-16-11, Pluristem Therapeutics CEO Letter to Shareholders
Reply New Message
Back To Forum List View
Icon president 5-16-11, Pluristem Therapeutics CEO Letter to Shareholders
3
emit
May 16, 2011 12:59PM
Icon president Re: 5-16-11, Pluristem Therapeutics CEO Letter to Shareholders
3
EDIGOKIE
May 16, 2011 03:02PM

I agree, only thing I don't like is their explaining that it'll be 3 years before commercialization.

But a lot could happen between now and then; we're up today on the oppenhimer coverage due to the presentation.

e

1 Recommendations
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply